Collection Resources

• Recommendations for Assessment of Blood Donor Eligibility, Donor Deferral and Blood Product Management in Response to Ebola Virus

  Tags Ebola, Example, Lab, Laboratory, Public Health, R-T&C, Specimen Collection, Specimen Handling, Therapeutics
  Creator: U.S. Food and Drug Administration
  Subject: Treatment & Care
  Item Type: Guide
  Date Last Updated: 2017-01-01
  Description: This guidance represents the current thinking of the Food and Drug Administration (FDA or Agency) on this topic. It does not establish any rights for any person and is not binding on FDA or the public. You can use an alternative approach if it…

  Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.

• Completing the Development of Ebola Vaccines: CURRENT STATUS, REMAINING CHALLENGES, AND RECOMMENDATIONS

  Tags Clinical Trial, Ebola, Ethics, Federal Research Partners, Prophylaxis, Public Health, R-Res&Pub, R-T&C, Research Design, Vaccine Study
  Creator: University of Minnesota, Center for Infectious Disease Research and Policy
  Subject: Treatment & Care
  Item Type: Publication
  Date Last Updated: 2017-01-17
  Description: In the third major report from the Wellcome Trust–CIDRAP Ebola Vaccine Team B reflects on progress to date and the remaining challenges faced.
• 

  Planning Guidance for Handling Category A Solid Waste: Managing Solid Waste Contaminated with a Category A Infectious Substance

  Tags Category A, NSPS 1, NSPS 2, NSPS 3, NSPS 4, R-WM, Special Pathogens, Waste Management
  Creator: U.S. Department of Transportation
  Subject: Waste Management
  Item Type: Guide
  Date Last Updated: 2024-04-01
  Description: What this is for: This Guidance is for safe handling of solid waste contaminated with a Category A infectious substance (henceforth, “contaminated waste”) and the proper management of inactivated Category A waste materials in the United States.* An…

• Care and Protection of Children in the West African Ebola Virus Disease Epidemic: Lessons learned for future public health emergencies

  Tags Ebola, Pediatrics, Public Health, R-SP, R-T&C, Treatment and Care
  Creator: Alliance for Child Protection in Humanitarian Action, UNICEF
  Subject: Treatment & Care
  Item Type: Guide
  Date Last Updated: 2017-01-23
  Description: Report and webinar about child protection response with Ebola.

• Integrating Clinical Research into Epidemic Response

  Tags Clinical Trial, Ebola, Ethics, Master Protocol, Prophylaxis, R-Res&Pub, Research Design, Special Pathogens, Therapeutics
  Creator: National Academies Press
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2017-04-12
  Description: Table of Contents   Front Matter i-xxvi Summary 1-18 1 Introduction 19-36 2 Conducting Clinical Research During an Epidemic 37-82 3 Assessment of Therapeutic Trials 83-112 4 Assessment of Vaccine Trials 113-154 5…

• Health Sector Resilience Checklist for High-Consequence Infectious Diseases

  Tags Communications, Decontamination, Ebola, Emergency Management, EMS, Epidemic, High Consequence Infectious Disease (HCID), Identify, Infection Prevention and Control, Inform, Isolate, Lab, Laboratory, Medical Surveillance, Outbreaks, Patient Transport, Person Under Investigation (PUI), Public Health, Quarantine, R-EM, Special Pathogens, Temperature Monitoring
  Creator: Johns Hopkins Center for Health Security
  Subject: General
  Item Type: Checklist
  Date Last Updated: 2017-05-24
  Description: Using lessons learned from treating Ebola patients in the US during the 2014-2016 Ebola epidemic in West Africa, this paper works to develop an evidence-informed checklist that outlines action steps.

• Flexible Clinical Trial Design Suitable for Emerging Disease Outbreaks

  Tags Clinical Trial, Ebola, Master Protocol, Prophylaxis, R-Res&Pub, Research Design, Special Pathogens, Therapeutics
  Creator: U.S. Food and Drug Administration (FDA)
  Subject: Research
  Item Type: Guide
  Date Last Updated: 2018-08-13
  Description: FDA CDER statisticians are designing trials with adaptive features to make clinical evaluation of new drug treatments more efficient and informative. (FDA)

• Consultation on Monitored Emergency Use of Unregistered and Investigational Interventions (MEURI) for Ebola Virus Disease (EVD)

  Tags Ebola, Prophylaxis, R-T&C, Therapeutics
  Creator: WHO
  Subject: Treatment & Care
  Item Type: Guide
  Date Last Updated: 2018-08-27
  Description: A group of independent scientific experts were convened by the WHO for the purpose of updating the May 2018 statement on MEURI for Ebola virus disease (EVD) during the current outbreak, 27 August 2018. (1)

• Working with People and Communities in Urban Humanitarian Crises

  Tags Communications, Ebola, Emergency Management, Epidemic, Epidemiology, Outbreaks, Public Health, Quarantine, R-EM, R-Res&Pub, Special Pathogens
  Creator: Active Learning Network for Accountability and Performance in Humanitarian Action
  Subject: Emergency Management
  Item Type: Publication
  Date Last Updated: 2017-06-01
  Description: This Working Paper explores the topic of working with urban populations and communities.

• Ebola Response in Cities

  Tags Communications, Ebola, Emergency Management, Epidemic, Epidemiology, Outbreaks, Public Health, Quarantine, R-EM, R-Res&Pub
  Creator: Active Learning Network for Accountability and Performance in Humanitarian Action
  Subject: Emergency Management
  Item Type: Publication
  Date Last Updated: 2017-06-26
  Description: In November 2014, ALNAP launched a sub-group of the Urban Response Community of Practice (CoP) to gather learning from the urban aspects of the Ebola Virus Disease (EVD) response in West Africa.